Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Mrazek

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|May 10, 2008
The ABPN Maintenance of Certification Program for psychiatrists: past history, current status, and future directionsLarry R Faulkner, Patricia W Tivnan, Daniel K Winstead, et al.
Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|January 7, 2011
Recent trends in american board of psychiatry and neurology psychiatric subspecialtiesLarry R Faulkner, Dorthea Juul, Naleen N Andrade, et al.
Pharmacogenetics and Genomics|December 31, 2010
CYP2C19 variation and citalopram responseDavid A Mrazek, Joanna M Biernacka, Dennis J O'Kane, et al.
Plos One|February 2, 2011
Functional role of the polymorphic 647 T/C variant of ENT1 (SLC29A1) and its association with alcohol withdrawal seizuresJeong-Hyun Kim, Victor M Karpyak, Joanna M Biernacka, et al.
The American Journal on Addictions|June 22, 2013
Alcohol craving as a predictor of relapseTerry D Schneekloth, Joanna M Biernacka, Daniel K Hall-Flavin, et al.
Archives of Neurology|March 15, 2006
Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment: a prospective cohort studyYonas E Geda, David S Knopman, David A Mrazek, et al.
British Journal of Clinical Pharmacology|February 18, 2014
Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associationsYuan Ji, Daniel J Schaid, Zeruesenay Desta, et al.
Pharmacogenetics and Genomics|January 18, 2013
FKBP5 genetic variation: association with selective serotonin reuptake inhibitor treatment outcomes in major depressive disorderKatarzyna A Ellsworth, Irene Moon, Bruce W Eckloff, et al.
Addiction Biology|August 7, 2012
Association of GATA4 sequence variation with alcohol dependenceVictor M Karpyak, Stacey J Winham, Joanna M Biernacka, et al.
Pharmacogenetics and Genomics|February 11, 2012
Merging pharmacometabolomics with pharmacogenomics using '1000 Genomes' single-nucleotide polymorphism imputation: selective serotonin reuptake inhibitor response pharmacogenomicsRyan Abo, Scott Hebbring, Yuan Ji, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|May 10, 2008
The ABPN Maintenance of Certification Program for psychiatrists: past history, current status, and future directionsLarry R Faulkner, Patricia W Tivnan, Daniel K Winstead, et al.
Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|January 7, 2011
Recent trends in american board of psychiatry and neurology psychiatric subspecialtiesLarry R Faulkner, Dorthea Juul, Naleen N Andrade, et al.
Pharmacogenetics and Genomics|December 31, 2010
CYP2C19 variation and citalopram responseDavid A Mrazek, Joanna M Biernacka, Dennis J O'Kane, et al.
Plos One|February 2, 2011
Functional role of the polymorphic 647 T/C variant of ENT1 (SLC29A1) and its association with alcohol withdrawal seizuresJeong-Hyun Kim, Victor M Karpyak, Joanna M Biernacka, et al.
The American Journal on Addictions|June 22, 2013
Alcohol craving as a predictor of relapseTerry D Schneekloth, Joanna M Biernacka, Daniel K Hall-Flavin, et al.
Archives of Neurology|March 15, 2006
Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment: a prospective cohort studyYonas E Geda, David S Knopman, David A Mrazek, et al.
British Journal of Clinical Pharmacology|February 18, 2014
Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associationsYuan Ji, Daniel J Schaid, Zeruesenay Desta, et al.
Pharmacogenetics and Genomics|January 18, 2013
FKBP5 genetic variation: association with selective serotonin reuptake inhibitor treatment outcomes in major depressive disorderKatarzyna A Ellsworth, Irene Moon, Bruce W Eckloff, et al.
Addiction Biology|August 7, 2012
Association of GATA4 sequence variation with alcohol dependenceVictor M Karpyak, Stacey J Winham, Joanna M Biernacka, et al.
Pharmacogenetics and Genomics|February 11, 2012
Merging pharmacometabolomics with pharmacogenomics using '1000 Genomes' single-nucleotide polymorphism imputation: selective serotonin reuptake inhibitor response pharmacogenomicsRyan Abo, Scott Hebbring, Yuan Ji, et al.
Pageof 6